Mesothelioma New Protocol: Atezolizumab with Carbo-Pem-Bev for Pleural Mesothelioma Ulas D. Bayraktar, MD 2025-05-04
Mesothelioma New Reference: Pembrolizumab with CISplatin and PEMEtrexed in Mesothelioma Ulas D. Bayraktar, MD 2024-06-22
Mesothelioma New Indication: Lenvatinib with Pembrolizumab in Pleural Mesothelioma Ulas D. Bayraktar, MD 2023-11-20
